Table 1 from The Preclinical Pharmacology of Tepotinib—A Highly Selective MET Inhibitor with Activity in Tumors Harboring MET Alterations
收藏Figshare2023-07-05 更新2026-04-28 收录
下载链接：
https://figshare.com/articles/dataset/Table_1_from_The_Preclinical_Pharmacology_of_Tepotinib_A_Highly_Selective_MET_Inhibitor_with_Activity_in_Tumors_Harboring_i_MET_i_Alterations/23627327
下载链接
链接失效反馈官方服务：
资源简介：
Summary table of completed and ongoing sponsor-initiated phase I and II clinical trials with tepotinib in patients with cancer.
创建时间：
2023-07-05
